episil® oral mucositis pain management episil® in an effective, safe and convenient new pain treatment for patients suffering from oral mucositis. The product is granted FDA 510(k) market clearance in the US and CE mark in EU. episil® is being launched globally by Camurus and its partners. Read more »
FluidCrystal® Injection depot Compatibility with prefilled syringes and autoinjectors, tuneable release profiles, and simple manufacturing, makes the FluidCrystal® injection depot stand out as a leading technology for daily, weekly, or monthly extended release products.
Meet Camurus at MASCC 2013 Camurus is attending the annual international symposium on cancer supportive care, MASCC in Berlin, June 27-29. If you plan to go, please do not miss the opportunity to meet with the Camurus team. Read more »